Evidence map›Paper›PMID 42414569›Full record

ArticleCommunications chemistry2026

msBayesImpute as a versatile framework for addressing missing values in biomedical mass spectrometry proteomics data.

Jiaojiao He, Barbara Helm, Franziska Gödtel, Katharina Büchner, Marcel Schilling, Marc A Schneider, Laura V Klotz, Jana Braunger, Hauke Winter, Britta Velten and 2 more

Abstract read
In one paragraph

Article in Communications chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Jiaojiao HeInstitute for Computational Biomedicine, Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.ORCID http://orcid.org/0009-0005-5492-6081
Barbara HelmSystem Biology of Signal Transduction, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Franziska GödtelSystem Biology of Signal Transduction, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Katharina BüchnerSystem Biology of Signal Transduction, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Marcel SchillingSystem Biology of Signal Transduction, German Cancer Research Center (DKFZ), Heidelberg, Germany.ORCID http://orcid.org/0000-0002-9517-5166
Marc A SchneiderTranslational Lung Research Center Heidelberg (TLRC), Member of the German Center for Lung Research (DZL), Heidelberg, Germany.ORCID http://orcid.org/0000-0001-8269-3821
Laura V KlotzTranslational Lung Research Center Heidelberg (TLRC), Member of the German Center for Lung Research (DZL), Heidelberg, Germany.
Jana BraungerBiological Data Science, Center for Organismal Studies (COS), Heidelberg University, Heidelberg, Germany.ORCID http://orcid.org/0000-0003-0820-9987
Hauke WinterTranslational Lung Research Center Heidelberg (TLRC), Member of the German Center for Lung Research (DZL), Heidelberg, Germany.
Britta VeltenBiological Data Science, Center for Organismal Studies (COS), Heidelberg University, Heidelberg, Germany.ORCID http://orcid.org/0000-0002-8397-3515
Ursula KlingmüllerSystem Biology of Signal Transduction, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Junyan LuInstitute for Computational Biomedicine, Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany. junyan.lu@uni-heidelberg.de.ORCID http://orcid.org/0000-0002-9211-0746

Funding

Bundesministerium für Bildung und Forschung (Federal Ministry of Education and Research) 031L0213Deutsche Forschungsgemeinschaft (German Research Foundation) SFB 1709/1 2025 - 533056198
6 · The paper itself

Abstract

Advancements in mass spectrometry (MS) technologies have significantly improved the ability to quantify proteins and analyse their modifications. However, MS-based proteomics datasets frequently encounter missing values due to a complex interplay of missing at random (MAR) and missing not at random (MNAR) mechanisms. Such missing data can result in information loss and biased outcomes in data pre-processing, as well as subsequent analyses and interpretations. Few approaches effectively address both MAR and MNAR, and those that do often necessitate manual tuning of mixture percentages between them or rely on two-group experimental designs. Therefore, we developed msBayesImpute, an innovative computational method that integrates Bayesian factorization with probabilistic dropout models. We evaluated msBayesImpute against several popular imputation methods using both simulated missing values and those generated through a dilution series experiment on samples from lung cancer patients. Our comprehensive benchmark demonstrated superior performance in reconstructing missing values, estimating normalization factors, identifying differentially expressed proteins and predicting outcomes with machine learning models across varying levels of missingness and sample sizes. Notably, msBayesImpute does not require predefined experimental designs and is scalable to large-scale studies. This versatility positions msBayesImpute as an effective and robust tool for enhancing the utility of MS datasets in biological research.

Identifiers

PMID42414569
PMCPMC13342297

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.